07:42 AM EDT, 08/14/2025 (MT Newswires) -- Atai Life Sciences ( ATAI ) on Thursday reported a Q2 loss of $0.14 per share, narrowing from a loss of $0.36 a year ago.

Analysts surveyed by FactSet expected loss of $0.09.

Revenue for the quarter ended June 30 was $719,000, up from $273,000 a year earlier.

Analysts surveyed by FactSet expected nil revenue.

As of June 30, the company said it had cash, cash equivalents and short-term securities of $95.9 million, compared to $72.3 million as of Dec. 31, 2024.